Zobrazeno 1 - 10
of 12
pro vyhledávání: '"A. V. Kapashin"'
Autor:
E. D. Volnaya, S. V. Teplykh, V. V. Popova, O. A. Vasilevskaya, E. A. Polyakova, S. E. Ushakova, V. B. Shunkov, A. A. Globenko, A. V. Kapashin, M. A. Pasko
Publikováno v:
Антибиотики и Химиотерапия, Vol 69, Iss 5-6, Pp 35-42 (2024)
Aim. Justification of the optimal dosage regimen regarding the efficacy and safety of Eladis®, film-coated tablets, 10 mg (Valenta Pharm JSC, Russia) in comparison with placebo in patients with non-productive cough due to acute respiratory viral i
Externí odkaz:
https://doaj.org/article/b8758ad8892f414b840e1590df55e1b4
Autor:
I. E. Shohin, S. M. Noskov, A. A. Globenko, N. S. Bagaeva, K. K. Karnakova, O. M. Parulya, L. N. Lutskova, A. V. Kapashin, M. A. Pasko
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 2, Pp 3-11 (2024)
Aim. A comparative study of the pharmacokinetics and safety of the investigational drug Duonica®, enteric-soluble, film-coated tablets, 10 mg + 10 mg (Valenta Pharm JSC, Russia) and the reference drug Diclectin®, delayed-release tablets, 10 mg + 10
Externí odkaz:
https://doaj.org/article/ba3dd3d5222342d0a032d8d0a620c8b6
Autor:
V. A. Stepanov, S. V. Ponasenkova, E. S. Simonova, P. D. Sobolev, A. G. Nikiforova, A. A. Globenko, A. V. Kapashin, M. A. Pasko
Publikováno v:
Антибиотики и Химиотерапия, Vol 68, Iss 11-12, Pp 30-37 (2024)
Topical use of antibacterial drugs as part of complex therapy for purulent-inflammatory infections of the skin and oropharynx can not only eliminate the symptoms but also influence the cause of the disease. Dioxidine® is a broad-spectrum antibacteri
Externí odkaz:
https://doaj.org/article/02815f12c2154f779faed4f23c8b22a8
Autor:
K. A. Zakharov, V. B. Vasilyuk, A. S. Goncharov, I. S. Goncharov, A. V. Losevich, A. V. Grigorev, E. V. Verbitskaya, A. A. Globenko, A. V. Kapashin, M. A. Pasko
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 4, Pp 32-40 (2024)
The aim. Study of pharmacodynamic parameters and confirmation of pharmacodynamic equivalence (bioequivalence) of the drugs Antareit® (INN: magaldrate), chewable tablets, 800 mg (Valenta Pharm JSC, Russia) and Riopan (INN magaldrate), chewable tablet
Externí odkaz:
https://doaj.org/article/8af787213f2d407ab13a03756c6001f6
Autor:
E. V. Baskakov, A. V. Grigorev, A. A. Globenko, A. G. Shmelev, E. A. Kolmykova, A. V. Yastrebova, A. A. Sidorova, A. V. Kapashin, O. V. Kovchan, A. I. Bashkatova, M. A. Pasko
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 3, Pp 94-103 (2023)
Aim. The primary aim of this study was to evaluate the pharmacokinetic parameters and confirm the bioequivalence of drugs containing gidazepam, namely Gidazepam® (Valenta Pharm, Russia) and Gidazepam VIC (VIVA Pharm, Republic of Kazakhstan), after
Externí odkaz:
https://doaj.org/article/c957ff2caa6c4ffaaba5d4fcf7d2fa60
Autor:
O. D. Ostroumova, M. L. Maksimov, M. V. Zamergrad, V. A. Parfenov, E. K. Zaharova, A. L. Vladykin, A. A. Globenko, A. V. Kapashin, K. A. Ishchenko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 4, Pp 53-65 (2023)
Objective: to evaluate the pharmacokinetic parameters, safety and tolerability of Vespireit® (INN buspirone), prolonged-release tablets, 15 mg (JSC “Valenta Pharm”, Russia), which is being developed as a drug for the treatment of functional vert
Externí odkaz:
https://doaj.org/article/1c0a0f3c1a3b413a9a5f047078d4eaf3
Autor:
A. S. Goncharov, A. V. Grigoriev, A. A. Globenko, I. S. Goncharov, K. A. Muratov, D. V. Yaroshenko, A. A. Sidorova, A. V. Kapashin, O. V. Kovchan, A. I. Bashkatova, M. A. Pasko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 4, Pp 80-88 (2023)
Objective: to study the pharmacokinetic parameters and safety of Dorsumio® (mirtazapine + tizanidine, extended-release tablets, 15 mg + 6 mg, JSC Valenta Pharm, Russia) taken once by healthy volunteers in comparison with Calixta®, a monocomponent d
Externí odkaz:
https://doaj.org/article/14b32c7fb8f54dc6be16e669eb7764ab
Autor:
V. B. Vasilyuk, Yu. A. Dzhurko, A. A. Globenko, L. N. Schitov, V. N. Shabrov, M. A. Pasko, O. V. Kovchan, A. V. Kapashin, A. I. Bashkatova
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 2, Pp 37-44 (2023)
The aim. The primary objective of the study was to evaluate the effect of food on the bioavailability of Aterixen® 100 mg tablet after single oral dose under fasting or fed conditions. The secondary objective was to evaluate the pharmacokinetic para
Externí odkaz:
https://doaj.org/article/953d6acf5708468fa5583386ddafe6f5
Autor:
I. G. Gordeev, V. I. Kazey, A. V. Kapashin, E. Е. Luchinkina, A. A. Globenko, А. L. Vladykin, E. A. Jain, A. I. Cherenkova, I. A. Kokorin, N. N. Levchuk, Т. V. Smolina, Р. D. Sobolev, S. Yu. Gorbacheva
Publikováno v:
Антибиотики и Химиотерапия, Vol 66, Iss 1-2, Pp 19-25 (2021)
Relevance. Pentanedioic acid imidazolyl ethanamide (PAIE) has been used clinically as an antiviral agent for a long time, however, there is no information in the available literature concerning the dependence of PAIE pharmacokinetics on isoenzymes po
Externí odkaz:
https://doaj.org/article/80543123a18547c9a7e048ffd9e3a8d7
Autor:
E. Е. Luchinkina, Р. D. Sobolev, S. Yu. Gorbacheva, V. I. Kazey, N. N. Levchuk, I. A. Kokorin, А. L. Vladykin, E. A. Jain, A. V. Kapashin, A. I. Cherenkova, A. A. Globenko, Т. V. Smolina, I. G. Gordeev
Publikováno v:
Antibiotics and Chemotherapy. 66:19-25
Relevance. Pentanedioic acid imidazolyl ethanamide (PAIE) has been used clinically as an antiviral agent for a long time, however, there is no information in the available literature concerning the dependence of PAIE pharmacokinetics on isoenzymes po